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Abstract
Sex-specific differentiation, development, and function of the reproductive system are largely 
dependent on steroid hormones. For this reason, developmental exposure to estrogenic and anti-
androgenic endocrine disrupting chemicals (EDCs) is associated with reproductive dysfunction in 
adulthood. Human data in support of “Developmental Origins of Health and Disease” (DOHaD) 
comes from multigenerational studies on offspring of diethylstilbestrol-exposed mothers/
grandmothers. Animal data indicate that ovarian reserve, female cycling, adult uterine 
abnormalities, sperm quality, prostate disease, and mating behavior are susceptible to DOHaD 
effects induced by EDCs such as bisphenol A, genistein, diethylstilbestrol, p,p′-dichlorodiphenyl-
dichloroethylene, phthalates, and polyaromatic hydrocarbons. Mechanisms underlying these EDC 
effects include direct mimicry of sex steroids or morphogens and interference with epigenomic 
sculpting during cell and tissue differentiation. Exposure to EDCs is associated with abnormal 
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DNA methylation and other epigenetic modifications, as well as altered expression of genes 
important for development and function of reproductive tissues. Here we review the literature 
exploring the connections between developmental exposure to EDCs and adult reproductive 
dysfunction, and the mechanisms underlying these effects.
Keywords
Developmental programming; epigenetic reprogramming; transgenerational transmission; DNA 
methylation; histone modification; non-coding RNA; reproductive behaviors; reproductive 
dysfunction
1. Introduction
In recent years, significant insights have been gained in our understanding of the critical 
roles of steroid hormones and other morphogens in orchestrating development, 
differentiation, and maturation of the reproductive system. These findings explain the 
exquisite sensitivity of the reproductive system to disruption by molecules that either mimic 
or disrupt steroid hormone actions. What remains to be uncovered are the long-term 
consequences of “environment by cell” and “environment by genome” interactions during 
critical developmental windows of the male and female reproductive systems and the 
mechanisms that govern these changes.
Here we discuss the concepts of windows of sensitivity to developmental disruption and the 
“Developmental Origins of Health and Disease” (DOHaD) hypothesis. We next review 
evidence from both human and animal studies that demonstrate developmental origins of 
adult reproductive dysfunction, and include detailed tabular summaries of this information. 
Examples of studies documenting mechanisms by which environmental exposures can lead 
to different types of epigenetic modifications to mediate DOHaD effects are provided. 
Finally, we review reports exploring the concept of transgenerational epigenetic inheritance 
of environmental exposures, and point out areas of research ripe for future exploration.
1.1. Timing of reproductive system development
Development of the mammalian reproductive system begins in early pregnancy with 
specification and migration of germ cells, followed by morphogenesis of the gonads, 
reproductive tract structures, and external genitalia. As the reproductive tissues form, they 
differentiate under the influence of numerous molecules including growth factors, 
transcription factors, and steroid hormones. Gross morphogenesis of reproductive tissues is 
largely complete before birth, but slow growth and regional and cellular differentiation 
continue through the onset of puberty. During puberty, a rapid phase of growth and 
additional structural and cellular reorganization occurs, regulated in large part by steroid 
hormones.
Some temporal aspects of reproductive system differentiation are distinct in females and 
males. For example, female germ cells enter meiosis prenatally and complete the initial 
phases of meiosis before birth, whereas male germ cells only begin to enter meiosis 
postnatally and continuously do so throughout adulthood. The protracted time period of 
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reproductive system formation, growth, and differentiation creates a wide window of 
susceptibility to disruption by environmental factors, and because of differences in timing of 
specific developmental events, this window differs in some aspects between females and 
males.
1.2. Developmental origin of adult diseases – windows of susceptibility
The DOHaD hypothesis proposes that the environment an individual experience during early 
development, can affect their sensitivity to, or risk of developing, disease later in life [1]. 
During development, dynamic interplay between the genome, epigenome, and stochastic and 
environmental factors contributes to the fate of individual cells to form functional organ 
systems in a “developed” adult state with stably differentiated tissues. That these tissue 
systems are stably, rather than terminally differentiated, allows for continual maintenance of 
a critical balance between cell death and proliferation, regeneration, and repair [2]. Most 
cells or organs have various degrees of phenotypic plasticity, whereby the phenotype 
expressed by a genotype is dependent on environmental influences [3]. The principle that the 
nutritional, hormonal, and metabolic environment afforded by the mother may permanently 
program the structure and physiology of her offspring was established long ago [4]. The 
DOHaD theory has now advanced to extend the critical developmental temporal windows of 
tissue reprogramming beyond in utero development to include preconception, perinatal, 
neonatal, postnatal, and pubertal development [5] (Figure 1). These adaptive traits are 
usually beneficial to the health of the individual. However, exceptions arise when an 
individual who is developmentally adapted to one environment is exposed to a contradictory 
environment [6]. Such exposures include the introduction of new chemicals and pollutants, 
which may increase the risk of developing disease later in life.
A prime example is the strong correlation observed between gestational exposure to 
diethylstilbestrol (DES) and increased female and male reproductive tract structural 
anomalies including a rare form of cancer, an increased infertility rate and poor pregnancy 
outcomes in female offspring, and an increased incidence of genital abnormalities and 
possibly urological cancers in male offspring [7–9]. Fetal exposure to environmental 
chemicals with estrogenic or anti-androgenic action can disrupt testosterone synthesis and 
sexual differentiation, leading to adult testis dysfunction and infertility [10–13]. In addition, 
exposure to endocrine disrupting chemicals (EDCs) during fetal life disrupts female 
reproductive tract development by altering expression of genes encoding secreted signaling 
proteins critical for directing this process [14]; these effects have permanent consequences 
for reproductive tract morphology and function in both rodents and humans [15, 16].
In summary, many of the developmental differentiation events critical for reproductive 
function, are dependent at least in part on steroid hormone signaling [14, 17–20]. For this 
reason, exposure to environmental EDCs, during this critical window of reprogramming, 
may induce profound changes in regulatory signaling pathways, and have a significant 
impact on development in ways that affect later reproductive health [21]. This concept of 
DOHaD could easily be extended to other windows of susceptibility, although evidence from 
epidemiological, clinical, and experimental studies remain sparse for these windows.
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1.3. Epigenetics – as a mechanism shaping DOHaD
Epigenetic modifications are defined as heritable changes in gene function that occur 
without a change in the nucleotide sequence [6, 22–24]. In the context of DOHaD, 
epigenetics can be viewed as an important “biostat” that allows an organism or a tissue to 
switch on or off anticipatory gene transcription programs in response to environmental 
changes, leading to adaptive phenotypic alterations to enhance survival. Gene transcriptional 
programs are changed in both a functional and temporal context as immediate and long-term 
responses to environmental cues. DNA methylation, histone modifications, transcription of 
new micro- and long non-coding RNAs, and other higher order chromatin remodeling events 
establish new adaptive traits for the tissue or organism. These epigenetic modifications are 
generated, maintained, and removed by a class of proteins known as “chromatin modifying 
enzymes”. The expression of these enzymes is exquisitely sensitive to specific 
environmental changes. Conversely, undesirable inherited or sporadic epimutations [25], or 
dysregulation of the epigenome in a tissue by harmful environmental disruption, could lead 
to disease development.
The most well studied epigenetic modification to DNA is methylation of cytosine residues in 
the context of a CpG (5′-C-phosphate-G-3′) dinucleotide. Methylation of CpG rich regions 
of DNA generally confers relatively stable silencing of gene expression, whereas 
unmethylated CpG regions are more accessible to transcription factor binding, which leads 
to gene transcription [26]. DNA methyltransferases (DNMTs) are primarily responsible for 
placing methyl groups on CpG dinucleotides, whereas the ten-eleven translocation (TET) 
family proteins remove methyl groups. DNMT1 is primarily responsible for maintaining 
CpG methylation once these marks have been established. DNMT3A and DNMT3B carry 
out de novo DNA methylation, which is important in embryo and tissue development as well 
as differentiation [27, 28]. Therefore, the proper expression of DNMTs and TETs cannot be 
overlooked when assessing the impact of the environment on DNA methylation.
To begin to understand how differential methylation impacts gene expression, comparisons 
are being made between methylation patterns (methylome) and gene expression patterns 
(transcriptome) in specific disease states. These types of studies will allow us to examine the 
intersection of DNA methylation and gene expression and how the environment can impact 
these differences. One study in women analyzed global DNA methylation and gene 
expression in leiomyoma tissue compared to normal adjacent tissue [29]. In this study, 
overlap of differential methylation of promoter regions and gene expression was found in 55 
genes, and of these, three of them are known tumor suppressor genes that have been 
implicated in reproductive tract tumorigenesis. Hypomethylation of the promoter regions of 
these three genes correlated with decreased expression. This study demonstrates that the 
local environment (tumor vs. normal) also contributes to alterations in methylation patterns 
adding complexity to the resulting methylome and transcriptome. Of interest, this study also 
showed that the vast majority of genes with differential expression did not exhibit altered 
DNA methylation patterns at their promoter regions. This finding indicates other epigenetic 
mechanisms are involved, in a concerted manner, to control gene expression.
Another way transcription can be controlled epigenetically is the differential association of 
modified histones at various DNA regions (reviewed by [30]). Histones are closely 
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associated with DNA, and specific residues of the histone tails can be modified with methyl 
groups, acetyl groups, and many other molecules. To increase the complexity of this 
regulatory system, there are often different types of modifications to histones at many 
different residues along their tails. This concert of modified histones associated with specific 
gene loci often correlates with transcriptional activity [31]. For example, the association of 
trimethylated histone 3 at lysine 4 (H3K4me3) at the promoter region is usually indicative of 
an actively transcribing gene. Conversely, trimethylated histone 3 at lysine 27 (H3K27me3) 
is usually associated with repression of gene expression [32, 33], although neither are 
exclusive and can co-exist (bivalency; [34]) in a careful balance to place a specific gene in a 
poised state – ready for transcription by cellular stimulus. Segregation of genes into active, 
repressed, bivalent, or poised is often achieved by an intricate balance between H3K4me3 
and H3K27me3 occupancy as reviewed by Weng et al (2012; [35]). The coordination of 
DNA methylation and histone modification, to define the transcriptional state and readiness 
of a cohort of genes, are commonly noted in most physiological and pathological states [36].
In addition to DNA methylation and histone modification, microRNAs (miRs) and other 
non-coding RNAs can also be dysregulated by EDCs. In a mouse study, prenatal exposure to 
vinclozolin led to the upregulation of microRNAs such as mir-23b and let-7 in embryonic 
day (E) 13.5 primordial germ cells [37]. Such microRNA dysregulation was observed in 
three successive generations, but no prominent DNA methylation changes were found [37]. 
However, in a similar vinclozolin study in rats, DNA methylation abnormalities and 
transcriptional changes were observed in the E13 and E16 germ cells [38]. At present, the 
broad view that EDCs exert long-term effects via the epigenetic action of miRNAs/non-
coding RNAs is still under construction, especially in the context of reproductive tract 
development.
2. Developmental origins of adult reproductive dysfunction associated with 
environmental factors – evidence from human studies
Human studies detailing female and male developmental origins of adult reproductive 
dysfunction associated with environmental factors are summarized in Table 1.
2.1. Female
DES is a potent synthetic estrogen, historically prescribed to pregnant women during the 
1940s–70s to prevent miscarriage. The consequences of exposing pregnant women to DES 
made clear not only the impact of EDCs on female reproductive tract development, but also 
the importance of timing of exposure during critical developmental windows in determining 
the extent of reproductive tract abnormalities. Prenatal DES exposure has been conclusively 
linked to the development of vaginal clear-cell adenocarcinoma in young female offspring 
(“DES daughters”) [39, 40], with a higher rate of incidence occurring in association with 
first trimester exposure [41]. A range of reproductive tract abnormalities have also been 
observed in DES daughters, including structural abnormalities of the uterus, vaginal 
adenosis, and malformations of the cervix (reviewed by [42–46]). A higher incidence and 
higher severity of abnormalities after earlier exposure to higher doses have been documented 
[47].
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Presently, a notable source of exogenous estrogen exposure to humans comes from dietary 
phytoestrogens [48], most commonly from soybean-derived foods rich in genistein and 
daidzein. Relatively high levels of these compounds are also found in soy-based infant 
formulas, consumed by an estimated 12% of infants in the United States (US) [49]. Infants 
fed an exclusive diet of soy infant formula have urinary genistein concentrations that are 500 
times higher than infants who are breast fed, or fed cow milk formula [50]. A number of 
recent studies have investigated associations between postnatal exposure to soy infant 
formula and adult female reproductive tract morbidities and symptoms. One study found that 
women fed soy-based formula as infants reported longer menstrual bleeding and more 
dysmenorrhea than women who had been fed cow milk formula [51]. This study did not 
report any association between infant feeding type and other reproductive organ problems 
such as endometriosis or uterine fibroids, yet notably, excessive bleeding and discomfort are 
common symptoms of these conditions [52].
DES and soy-based products continue to be studied as early-life factors associated with adult 
female reproductive health. At 10 years of follow up in a Nurses’ Health Study, the 
incidence rate of endometriosis was found to be 80% greater among women exposed to DES 
in utero [53]. A similar result was reported in a population-based case-control study, where 
both prenatal DES exposure and “regular” soy formula feeding during infancy were 
associated with an increased risk of surgically confirmed endometriosis [54]. Uterine 
fibroids have also been associated with these early-life factors, but with some inconsistency. 
A cohort study of almost 20,000 non-Hispanic white women from the National Institute of 
Environmental Health Sciences (NIEHS) Sister Study, linked use of soy formula during 
infancy with a slightly increased risk of early uterine fibroid diagnosis [55]. Prenatal DES 
exposure has also been associated with increased incidence of uterine fibroids [15, 56] and 
increased risk of early-onset fibroids among non-Hispanic black women [55]. However, 
other studies have not supported the associations between fibroids and prenatal DES [57] or 
soy formula [58, 59]. In an ongoing cohort by the NIEHS, no association was observed 
between infant soy formula feeding and fibroid prevalence in African-American women, 
aged 23–34 years, who had no diagnosis of fibroids at enrollment [60]. However, soy 
formula-exposure was associated with a 32% increase in fibroid diameter, and a 127% 
increase in total fibroid volume [60]. Within this cohort, the data also suggest an association 
between soy-based infant formula feeding and heavy menstrual bleeding [61].
A common limitation of many of the aforementioned studies is that they rely on the 
participant’s recall of retrospective exposure. Although prospective studies of prenatal DES 
exposure are not feasible due to the banning of its use in humans, a number of prospective 
studies examining the potential effects of soy exposure through soy-based infant feeding are 
underway. Using data from a longitudinal cohort of children followed from infancy to 
adolescence, Adgent et al reported a slightly increased risk of menarche in early adolescence 
in association with soy formula exposure [62]. Another prospective study showed increased 
estrogenization of vaginal epithelium in soy fed infants compared to cow milk fed infants 
[63] and a recent follow up study of the same infants showed differential methylation 
patterns in those vaginal epithelial cells [64]. These findings demonstrate a direct connection 
in humans between soy formula exposure and temporarily altered epigenetic marks in an 
estrogen-responsive tissue. Other ongoing studies specifically designed to evaluate the 
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effects of soy formula feeding, compared to breast milk or cow milk formula, on 
reproductive organ volume and characteristics at 4 months [65] and 5 years [66] of age, have 
reported no significant differences between the diet groups. Continued follow-up of these 
cohorts will be important to help delineate potential early infant feeding effects of soy on 
reproductive function later in life.
Another EDC that has estrogenic and/or anti-androgenic activity is bisphenol A (BPA), one 
of the highest-volume chemicals produced in the US. BPA is widely used in the manufacture 
of polycarbonate plastic, epoxy resins and many other consumer products [67] and is readily 
detected in the urine of over 95% of the US population [68]. Higher urinary BPA levels are 
associated with a decreased number of oocytes and mature oocytes [69], and recurrence of 
miscarriages, as well as with women undergoing in vitro fertilization [70]. The mechanisms 
involved in the development of these reproductive diseases are yet to be fully understood.
In addition to estrogenic and anti-androgenic chemicals, recent population studies have 
examined the effects of environmental chemicals that disrupt homeostasis of thyroid 
hormone and growth hormone actions during the prepubertal period [71, 72]. Study findings 
showed that in utero exposure to higher levels than median of polychlorinated dibenzo-p-
dioxins and dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs) results in lower 
estradiol concentrations in eight year-old children, and that girls had impaired reproductive 
tract development including shorter uteri and fundi lengths [73].
Taken together, these studies suggest that EDCs impact human female reproductive health. 
Although these studies are beginning to reveal deleterious effects, more extensive studies on 
EDC exposures and potential consequences on reproduction are warranted.
2.2. Male
According to the National Survey of Family growth, about 12% of men at the reproductive 
age of 25–44 are subfertile [74]. Although in many cases the etiology remains largely 
unknown, developmental exposure to environmental agents is emerging as a contributing 
factor. The impact of environmental estrogens (herbicides, pesticides, PCBs, plasticizers, 
and polystyrenes) and anti-androgens (polyaromatic hydrocarbons, linuron, vinclozolin, and 
p,p′-dichlorodiphenyl-dichloroethylene (pp′-DDE)) on male sexual differentiation [75] and 
the testis [76] have been extensively reviewed, however, literature specific to DOHaD 
regarding the male reproductive system is limited.
A multi-cohort study of DES-exposed sons [77] showed that prenatal exposure to DES is 
associated with an increased risk of male urogenital tract abnormalities including 
cryptorchidism, epididymal cysts, and inflammation/infection of the testis. The association 
was strongest in men exposed during the first trimester [77]. These findings strongly support 
that the root cause of disruption is during the period of sexual differentiation, as epididymal 
cysts are related to the persistence of müllerian remnants, and testicular descent is dependent 
on the estrogen-sensitive hormone, insulin-like growth factor 3, secreted by the Leydig cells 
in the fetal testis [78]. Earlier observations [79–81] that gestational exposure to DES 
elevated risk of hypospadias were not confirmed in this collaborative cohort study. There are 
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conflicting results in the literature regarding whether or not DES-exposed males have an 
increased risk of infertility [82, 83].
In addition to DES, there is increasing evidence that developmental exposure to BPA affects 
male reproduction (reviewed by [84]). Of particular concern is the finding that pregnant 
women have higher urinary BPA levels than non-pregnant women, suggesting that there is 
higher exposure to the fetus than was once thought [85]. Although maternal blood 
concentrations of ~2.5 ng/mL versus umbilical cord blood concentrations of ~0.5 ng/mL 
suggest a certain degree of placental protection, elevated risk of lower birth weight, smaller 
size for gestational age, higher fetal leptin, and lower adiponectin were observed in male 
newborns in the highest quartile of maternal BPA exposure [86]. Furthermore, children 
between the ages of 0 and 2 are now identified as a higher risk population for BPA exposure 
[87] because they have a lower capacity to metabolize BPA due to low expression of the 
liver enzyme, uridine 5′-diphospho-glucuronosyltransferases [88]. Therefore, early-life 
exposure to even low doses of BPA may have a greater impact on adult disease outcomes 
than anticipated based on dose levels [89].
Similarly, other epidemiological studies have linked in utero exposure to smoking 
particulates, PCB, PCDF, perfluorooctanoic acid, dioxin, and 2,3,7,8-
tetrachlorodibenzodioxin (TCDD) to reduced semen concentration, and sperm count [90–
92], reduced number of morphologically normal sperm, motile, and rapidly motile sperm 
[93] and smaller testis [90]. Further, in a small case control study, maternal exposure to 
higher levels of persistent organic pollutants including PCBs, pp′-DDE, hexachlorobenzene, 
chlordanes and polybrominated dibenzoethers (PBDEs) was found to be associated with 
increased testicular cancer risk [94]. Because these chemicals, especially pp′-DDE, are 
known for their endocrine disruption as anti-androgens, one can speculate that early-life 
disruption of androgen signaling reprograms cancer risk in testes.
These studies suggest developmental exposures to EDCs impact reproductive health in men 
as well as women. Again, more studies on EDC exposures to males during critical periods of 
development and their effects on subsequent reproduction and reproductive disease are 
warranted.
3. Developmental origins of adult reproductive dysfunction associated with 
environmental factors – evidence from experimental studies
There have been numerous animal studies documenting the adverse effects of EDCs on the 
developing female and male reproductive systems. A comprehensive list of these studies, 
which thoroughly validate the concept of developmental origins of reproductive dysfunction 
associated with environmental factors, are provided in Table 2.
3.1. Reproductive tract
There are numerous animal studies documenting that environmental factors strongly 
influence reproductive tract development and function. Indeed, studies performed on 
reproductive tract tissues highlight the importance of the timing of exposure to the outcome. 
In general, a differentiating tissue is more at risk of re-programming than a fully 
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differentiated tissue. One example in support of this thesis is the effect of neonatal exposure 
to genistein on external genitalia development in the mouse. Female mice complete 
formation of the urethra during the first several days following birth, when the urethral folds 
arising from urogenital sinus mesenchymal cells undergo fusion. If female mice are exposed 
to genistein during the first five days of life, they fail to complete urethral fold fusion and as 
a result, develop hypospadias [95]. Urethral formation in male mice, which is completed 
prior to birth, is unaffected by this treatment. These findings are in concordance with human 
studies (see above) that show DES exposure during the first trimester, when sex 
differentiation takes place, inflicts higher incidences of abnormalities in the male and female 
reproductive tract of offspring [41, 77].
In addition, a tissue that is actively proliferating to generate additional cells required to form 
the developing structure will respond differently to an insult as compared to a tissue that has 
already generated many of the required cells and is undergoing a differentiation process. 
One example to support this notion is that exposure of female mice to DES prenatally, 
during the period of major organogenesis of the reproductive tract, results in numerous gross 
morphological abnormalities of the reproductive tract and rare uterine adenocarcinomas, 
whereas DES exposure immediately after birth does not significantly affect gross 
morphology, but instead causes a high incidence of endometrial [96] and vaginal [97] 
adenocarcinoma. Hence, the developmental context of a tissue is a critical driver of 
outcomes related to environmental exposures.
Prolonged developmental plasticity of a tissue can be an underlying cause of adult disease 
development linked to early-life exposures [98, 99]. Tissue recombination studies highlight 
the plasticity of the female reproductive tract epithelium during differentiation. When paired 
with vaginal mesenchyme, uterine epithelial cells from neonatal mice will transdifferentiate 
to become morphologically similar to vaginal epithelial cells and express vaginal cell 
markers; a similar effect is observed when vaginal epithelium is paired with uterine 
epithelium [100–103]. Although the developmental plasticity of the female reproductive 
tract epithelium gradually decreases following birth, uterine and vaginal epithelium from 
two month old mice can still be transdifferentiated, albeit to a lesser extent than neonatal 
tissue [103], indicating that this tissue is in a stably (not permanently) differentiated state 
and suggesting that the window for reprogramming in this epithelium is well-extended into 
adulthood. This phenomenon has been well characterized in other tissues; most notably, 
neuroplasticity and hence behavior is well-extended into adulthood making the brain a 
highly sensitive organ for developmental reprogramming [104].
3.2. Ovary
Ovarian differentiation is clearly impacted by EDC exposure, with the outcome dependent 
on the stage of ovarian development when the exposure occurs. The number of female germ 
cells, which comprises the “ovarian reserve”, reaches its peak during gestation and continues 
to decline during the reproductive lifespan of female mammals [105, 106]. It is now 
established that the ovarian reserve is established during gestation through a complex 
interplay between homeobox transcriptional factors, hormones, and genetic determinants, a 
process that can be disrupted by environmental factors through multiple mechanisms 
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(reviewed by [105]). Some toxicants exert their action through induction of apoptosis during 
the breakdown of the germ cell nest, a critical step for establishing primordial follicles. 
Exposure to polycyclic aromatic hydrocarbons (PAHs), key toxicants in cigarette smoke, 
before pregnancy and/or during lactation reduces ovarian reserve in female mouse offspring 
through aryl receptor-mediated dysregulation of the cell death gene named harakiri [107]. In 
utero exposure to BPA similarly reduces the number of primordial follicles in mice. Other 
disruptors of ovarian reserve impact meiosis I progression in oocytes and reduce the overall 
primordial follicle pool in the developing ovaries as shown in prenatal BPA exposed 
offspring [108].
After gestation, the limited number of ovarian follicles are still susceptible to depletion by 
exposure to a wide-range of toxicants including DES, BPA, and genistein (reviewed by 
[109]). Further, postnatal exposure to DES induces the loss of mature follicles and functional 
corpora lutea in the ovaries of adult females [110]. The same treatment also reduces the 
mating preferences of these females, leading to infertility. In addition to targeting ovarian 
reserve, in utero exposure to EDCs (DES or BPA) decreases embryo implantation and 
increases embryo resorption [110].
Prenatal and postnatal exposure to androgen can cause anovulation [111], but whether the 
window of susceptibility remains open in later-life remains unclear. A recent study 
compared reproductive outcomes in female CD-1 mice given a single injection of a 
physiologically relevant dose of testosterone, 24 hours after birth or at the age of weaning 
(3–6 weeks) [111]. While a large percentage (66%) of the neonatally treated animals 
developed irregular cycles, were anovulatory, and had higher ovarian weights, none of these 
reproductive dysfunctions were observed in animals treated at the more advanced age 
period. This study indicates that the window of susceptibility of the ovary to reprogramming 
by environmental androgen mimics is similar to estrogens and occurs in differentiating 
tissues rather than adult tissues.
A consequence of altered ovarian function is altered hypothalamic/pituitary/gonadal 
signaling, which results in improper hormonal regulation of reproductive tract function. In 
fact, irregular cycles are a common symptom of prenatal exposure to EDCs or other 
infertility factors. This connection is difficult to document in humans because of the timing 
of exposure (developmental) and the latency between the exposure and the outcome 
(adulthood). In mice, in utero exposure to DES or BPA from gestational day (GD)11 until 
birth shortens the time between vaginal opening and the first estrus cycle [112]. Moreover, 
the exposures decrease the time in proestrus, and extends the time in metestrus. Because 
mating occurs precisely at estrus when ovulation occurs [113], the shortened estrus 
diminishes successful fertilization.
3.3. Testis
Male rodents have shown significant DOHaD effects for a number of EDCs including BPA. 
The finding that BPA is detectable in the fetal serum 30 minutes after the first single 
subcutaneous injection of BPA in GD17 mice [114] indicates that this agent can diffuse 
across the maternal placental barrier, exposing the fetuses to BPA. Furthermore, the liver 
enzymes responsible for BPA elimination are either absent or expressed at low levels during 
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the fetal and neonatal period [115], making early-life more susceptible to the impact of this 
EDC. Neonatal exposure of male rats to BPA is associated with elevated risk of prostate 
premalignant lesions [116–118]. Multiple studies confirm the potent effects of gestational 
exposure to environmentally relevant doses of BPA on impairing testicular functions 
(reviewed by [84]). This xenoestrogen was found to signal through estrogen receptor (ER)α 
and G-protein coupled estrogen receptor 1 (GPER1) to affect spermatogonial cell 
proliferation and syntheses of steroidogenesis enzymes in the testis, resulting in systemic 
endocrine disruption. Mice exposed to BPA also exhibit disruption of ERα and ERβ 
expression at the hypothalamic-pituitary-gonadal axis.
Transient in utero exposure to other estrogenic EDCs such as polybrominated diphenylethers 
(PBE) and TCDD decreased the weight of the testes and accessory glands of the adult male 
rat [119–121]. These treatments consistently reduced the number of spermatids in the testes, 
caudal epididymal sperm count, and daily sperm production, although sperm morphology 
and motility were within the normal range [119, 120]. Importantly, the overall fertility of the 
TCDD-exposed males declined, as indicated by a marked reduction in impregnated females 
with successive mating [120]. Similarly, exposure of mice to DES from GD12, and during 
lactation, significantly diminished the number of Sertoli cells and the epididymal sperm 
count in the adult mice [122]. These treatment regimens also reduced sperm motility and 
quality leading to a decrease in fertilization ability. Resulting zygotes were mostly arrested 
at the 2-cell stage, which accounted for the higher incidence of preimplantation embryo loss 
[122]. In another study, exposure of mice to DES from GD9 to 16 inhibited testicular 
descent and induced testicular lesions and/or epididymal cysts, leading to sterility in the 
offspring [123]. The developmental impact of the phytoestrogen genistein mimics that of 
DES. Neonatal exposure (postnatal day, PND 1–5) to genistein reduced epididymal weight 
and the number of germ cells in the seminiferous tubules [124]. However, in utero exposure 
to genistein did not affect sperm quality. The latter finding again demonstrates that the 
window of exposure is an important determinant of outcomes.
3.4. Mating Behavior
Abnormal social and sexual behavior linked to early-life exposure to environmental 
toxicants affects reproduction. Exposure to ethinyl estradiol on day 20 to 60 post-
fertilization causes the adult female zebrafish to be less attractive to the males during their 
spawning period [125]. Gestational and lactational exposure to BPA also increases the 
likelihood of female rats to investigate their partners and explore the new environment, but 
they are more reluctant to interact with their male mating partners [126]. Sexual behavior 
impairments were also observed in adult male rats prenatally exposed to PBE as they 
exhibited reduced ejaculation frequency during mating time [119]. Prenatal exposure to 
chlorpyrifo, an organophosphate insecticide, delayed neonatal motor maturation and altered 
sexual/mating behavior of male mice [127]. Adolescent exposure of male hamsters to 
anabolic/androgenic steroids promotes aggression and anxiety in adult-life [128]. Exposure 
of adult male mice to BPA suppressed sexual motivation and performance [129]. Other 
environmental agents that perturb sexual behavior include fluoxetine [130], diesel exhaust 
[131], PBDE and PCB [132], and a long list of environmental toxicants/pollutants (reviewed 
by [104]). The modes of action appear to be wide ranging, including acting as anti-
Ho et al. Page 11
Reprod Toxicol. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
androgens/androgens, activation of steroid hormone receptors [133], and inhibition of 
activation enzymes such as aromatase [134]. Other neuronal targets may include disruption 
of the melanocortical axis, and oxytocin/vasopressin signaling [133].
4. Epigenetics as a mediator of DOHaD
Upon fertilization, massive epigenetic modifications take place to erase the parental 
epigenetic marks while concomitantly building new marks in the totipotent zygote. As the 
pluripotent embryonic stem cells differentiate into distinct cell types, each with a unique 
epigenome, increased cellular differentiation leads to progressive chromatin restriction and 
loss of cellular plasticity in stably differentiated cells of an adult tissue [135, 136]. The 
process is accomplished through careful orchestration of epigenetic alterations leading to 
chromatin compaction and tissue-specification in various organs. The requirement of a high 
degree of spatial and temporal coordination provides opportunities for disruption by 
environmental chemicals. Although many molecular mechanisms are possible (see Section 
1.3), a few examples are provided here to demonstrate how exposure to specific 
environmental factors can lead to stepwise changes in epigenetic status and thereby 
functional alterations.
4.1. DNA methylation
Several studies have demonstrated the impact of developmental exposure to EDCs on DNA 
methylation patterns in female reproductive tissues. A paper from almost two decades ago 
showed that neonatal exposure to DES results in hypomethylation of specific CpGs in the 
promoter region of the lactoferrin (Ltf) gene [137]. Ltf is normally an estrogen responsive 
gene in the uterus, but DES-induced hypomethylation was correlated with aberrant 
expression of Ltf in the absence of estrogen throughout life, suggesting that a permanent 
alteration in the hormone responsiveness of the gene had occurred. A subsequent study using 
the same model examined uterine DNA methylation pattern differences in a non-biased way 
[138]. Several gene promoter regions were found to have differential methylation following 
neonatal DES or genistein exposure; one of these was Nsbp1 (now named Hmgn5), a protein 
that plays a role in chromatin compaction. The promoter region of this gene was 
hypomethylated later in life (6 months of age) following developmental exposure to either 
DES or genistein, and this was correlated with aberrant over-expression of uterine Nsbp1. 
Prenatal DES exposure results in hypermethylation of the Homeobox (Hox)a10 promoter 
that correlates with a decrease in gene expression [139]. In contrast, prenatal BPA exposure 
increases Hoxa10 expression through promoter hypomethylation [140]. HOXA10 is an 
important regulator of embryo implantation in the uterus and its expression is altered in a 
number of female reproductive tract pathologies including endometriosis and endometrial 
cancer [141–143]. Therefore, alterations in methylation patterns of these genes impacts their 
expression, and subsequently alters adult reproductive function. The specific examples given 
above are based on candidate approaches, but future global DNA methylation studies 
correlated with gene expression analysis will most likely reveal many more genes controlled 
in this manner.
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4.2. Histone modification
In addition to altered DNA methylation, EDC exposure during development impacts histone 
methylation. For example, rats treated postnatally with DES or genistein develop uterine 
leiomyomas by 16 months of age [144]. During the time of treatment, there is decreased 
global H3K27me3 in the uterus, which is attributed to increased phosphorylation of 
enhancer of zeste 2 (EZH2). EZH2 is a subunit of the polycomb repressive complex 2, a 
histone methyltransferase responsible for methylating H3K27. Because histone H3K27me3 
is predominantly associated with repressed genes, it was hypothesized that there would be an 
increase in expression of some genes due to low levels of H3K27me3. Differential 
expression of a few selected estrogen-responsive genes was observed during the time of 
treatment, and a subset were permanently altered in response to estrogen later in life. While 
this study does not definitively prove that lowering H3K27me3 levels results in leiomyoma 
formation, it does demonstrate the influence of developmental exposures to EDCs on 
epigenetic machinery and suggests this mechanism as a potential point of interference.
Another example of EDC impact on the epigenetic machinery comes from a recent study 
from our laboratory. Neonatal exposure to DES or genistein in mice causes uterine cancer 
later in life, but the mechanism responsible for this phenotype is not known. Estrogenic 
action is required because deletion of estrogen receptor alpha (Esr1) completely blocks DES 
induced changes [145], but the mechanisms underlying permanent alterations in gene 
expression have not been delineated. We demonstrated that mice treated neonatally with 
DES exhibited alterations in several parts of the epigenetic machinery [146]. The most 
striking findings were a severe reduction in the histone deacetylase (HDAC1, HDAC2, and 
HDAC3) protein levels and a modest reduction in the histone acetyltransferase, EZH2, 
during the time of treatment (PND1–5). Although these proteins were altered, no global 
differences in overall amount of histone acetylation at specific residues [acetylated histone 3 
at lysine 9 (H3K9ac) or acetylated histone 4 at lysine 5 (H4K5ac)] were observed. There 
was also a significant reduction in the histone acetylase, lysine acetyltransferase 2A, but no 
correlated difference in global histone methylation [H3K4me3, dimethylated histone 3 at 
lysine 9 (H3K9me2) or H3K27me3). However, there were significant differences in the 
locus-specific association of H3K4me3, H3K9ac and H4K5ac at the promoter regions of two 
highly differentially expressed genes, Ltf and Six1. In addition, the differential association 
of these activating marks at the promoter region of Six1 remained in adulthood, suggesting 
that permanent alterations in the epigenetic landscape resulted in aberrant expression of this 
gene throughout life. Importantly, overexpression of SIX1 is associated with several cancers 
including breast, uterine and cervical cancer [147, 148]. Future investigations are needed to 
elucidate the rules governing recruitment of these chromatin-modifiers to specific gene 
promoters, transcriptional factor binding sites, and enhancer/silencer elements during 
developmental reprogramming by environmental agents.
4.3. Methyl donors
One-carbon metabolism during pregnancy has a major impact on fetal development and the 
setting of methylation marks. Inadequate dietary intake of specific nutrients (folate, choline, 
betaine, B vitamins) impairs one-carbon metabolism, which in turn results in diminished 
availability of the methylation substrate, S-adenosyl methionine (SAM). SAM is required for 
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the establishment and maintenance of both DNA and histone methylation marks during fetal 
differentiation [149]. Because DNA methylation is a common mechanism for stable 
repression of transposable elements and for the establishment of tissue-specific gene 
expression along a differentiation pathway, SAM depletion in the fetus has a direct 
connection to how tissues differentiate and eventually function [150]. For example, in the 
mouse, supplementation of maternal diet with methyl donors ameliorates BPA-induced 
hypomethylation of the agouti gene promoter [151]. Hence, nutritional influence on methyl 
donor availability provides a mechanistic basis for developmental changes in epigenetic 
marks that can impact reproductive function in adults.
4.4. Alterations in chromatin remodeling proteins
Another point of impact of EDCs on reproductive function is altered gene expression/
repression. These alterations can directly or indirectly alter the levels of specific chromatin 
remodeling proteins within the cell or tissue, and as a result can modify the generation, 
removal, and maintenance of DNA methylation or specific histone marks. Neonatal BPA 
exposure elevates gene expression of specific DNA methylation enzymes (Dnmt1 and 
Dnmt3b) and methyl-CpG binding proteins (Mbd2, Mbd4) in PND10 prostate tissues [118]. 
Similarly, neonatal exposure to DES alters the expression of Dnmt3a, Dnmt3b, and Mbd2 in 
seminal vesicles [152]. Concordant aberrant methylation of gene promoters such as Hmgn5, 
Pde4d and Hpcal1 in adult prostate [116, 118] alters the expression and/or activities of DNA 
methylation enzymes or methyl-CpG binding protein gene expression through 
developmental reprogramming. Further studies of EDC-induced global alterations in 
chromatin modifying proteins and the resulting gene-associated epigenetic modifications, 
along with the effects on gene expression, are needed to fully understand the impact of these 
exposures.
Transcription factors that regulate differentiation during development are frequent targets of 
hormone action. Many hormonally active compounds interact with nuclear receptors to 
initiate rapid induction of alterations in gene expression, which are comprised of both 
transcriptional activation and repression. HOX transcription factors regulate the regional 
identity of tissues along the anterior-to-posterior body axis, including the male and female 
reproductive tracts. Expression of many HOX genes is altered by exposure to hormonally 
active chemicals, including estrogens, retinoic acid, and vitamin D, all of which interact with 
nuclear receptors to mediate their downstream effects [153]. These alterations in gene 
expression are accompanied by changes in histone modifications in the relevant gene loci as 
well as in enhancer regions regulating those loci. The new histone modifications can then be 
maintained and extended by chromatin remodeling proteins whose role is to perform 
maintenance activities for the histone marks. The end result is that the initial insult leads to 
stable alterations in expression of transcription factors that change the final differentiation 
status and function of the tissue.
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5. Transgenerational epigenetic inheritance of environmental exposures in 
reproduction
5.1. Transgenerational inheritance in reproduction – evidence from animal models
Environmentally-induced transgenerational epigenetic inheritance is defined as germline 
transmission of modified epigenetic information across generations in the absence of 
continued direct exposures [154]. Conclusive evidence of transgenerational effects of in 
utero exposure to environmental factors requires changes to persist through and beyond the 
Filial (F)3 generation – the great grand-offspring of the originally exposed generation – the 
first unexposed generation. For exposure occurring outside of pregnancy, transgenerational 
inheritance must persist through the F2 generation that has had no prior exposure.
Transgenerational effects of EDCs on the male reproductive system was first reported by 
Skinner et al in a series of studies involving exposure of pregnant dams to vinclozolin [155–
161]. Adverse transgenerational effects on male germ cells, testicular functions, and male 
fertility, accompanied by epigenomic (DNA methylation) and gene expression changes were 
observed in Sertoli cells of F3 or F4 generations derived from exposed F0 dams. Similar 
transgenerational impacts on the sperm and testis were also observed in animal models for 
ancestral exposure to a mixture of pesticide permethrin and insect repellent N,N-diethyl-
meta-toluamide (DEET) [162], insecticide dichlorodiphenyltrichloroethane (DDT) [163], a 
mixture of BPA, bis(2-ethylhexyl)phthalate (DEHP) and dibutyl phthalate [164], BPA [165], 
DEHP [166], benzo(a)pyrene [167], and TCDD [168, 169]. Furthermore, prostate 
abnormalities, including epithelial hyperplasia, glandular atrophy and prostatitis, were 
observed in the ventral prostate of older F3/F4 generation rats and mice derived from F0 
exposure to vinclozolin [170, 171]. The altered prostate phenotype was accompanied by 
transgenerational reprogramming of the expression of calcium and WNT signaling pathways 
[170]. In contrast, DDT-, plastic-, dioxin- or jet fuel exposures only elicit intergenerational 
effects on prostate disorders that appears in the F1 generation [163, 164, 172, 173]. Finally, 
male-mediated transgenerational behavioral changes were also observed in rats with 
ancestral exposure to vinclozolin [174]. Female rats, from control or exposed ancestors, 
avoided mating with males from the vinclozolin-lineage and preferred those from the control 
lineage. In contrast, males from both lineages exhibited no mate preference for females. 
Collectively, these findings demonstrate that transgenerational inheritance is specific to 
environmental pollutants and may affect multiple reproductive organs in subsequent 
generations of offspring even when the exposure has ceased.
5.2. Postulated mechanisms of environmentally-induced transgenerational epigenetic 
inheritance – heritable germline epigenome alterations
Epigenetic reprogramming has been proposed as the mechanism underlying 
transgenerational inheritance of reproductive dysfunction. A critical window of 
susceptibility has been identified to be during gonadal sex determination, a period marked 
by rapid and genome-wide DNA demethylation (Figure 2). Subsequent re-establishment of 
the DNA methylation marks is initiated during testicular and ovarian maturation [175–177]. 
Offspring (F3/F4) derived from pregnant F0 females exposed to vinclozolin during this 
window, from E8–E14 in rat [160, 161, 178, 179] or E7–E13 in mouse [171] displayed the 
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most persistent transgenerational changes. Persistent changes in transcriptome and DNA 
methylome of male primordial germ cells in the F3 generation were reported [38]. 
Alterations in mature sperm DNA methylome were detected with the same period of 
exposure to vinclozolin [180], methoxychlor [181], pesticides (permethrin and DEET) [162], 
plastic chemicals (BPA and phthalates), dioxin, and hydrocarbons [172]. Thus, the period 
during gonadal sex determination is recognized as highly sensitive to transgenerational 
epigenetic reprogramming by environmental toxicants.
Germline epigenetic marks are transmitted across generations, because they resist epigenetic 
erasure and resetting during post-zygotic embryogenesis and germline differentiation 
(Figure 2). It has been proposed that ancestral vinclozolin-induced differential methylation 
regions in sperm of F3 offspring may represent DNA demethylation escapees and are 
candidates of transgenerational epigenetic inheritance [172, 182]. Demethylation-resistant 
loci, including some classes of retrotransposons, have been identified in human and mouse 
germ cells [183–187]. Some escapees were incompletely reprogrammed in primordial germ 
cells, mature gametes, and preimplantation embryos [185, 187]. As such, these resistant loci 
may be vulnerable to environmental reprogramming, and become inheritable.
Evidence for the role of histone modification in transgenerational inheritance is currently 
lacking. This may be due to the rapid nature of histone modifications needed for chromatin 
remodeling during embryonic and germline development [183]. Another mechanism 
enabling epigenetic reprogramming in sperm [188] and oocytes [189–191] involves small 
noncoding RNA (sncRNA) populations including PIWI-interacting RNAs (piRNAs), 
microRNAs (miRNAs), nuclear sncRNAs [192], and endogenous small interfering RNAs 
(endo-siRNAs). These RNAs have now been implicated in gamete-mediated 
transgenerational epigenetic inheritance [183, 193–196]. Small RNAs, like piRNAs and 
endo-siRNAs, can serve as “sequence guides” to direct DNA methylation machinery or 
chromatin/histone modification complexes for targeting specific genomic loci [197]. The 
unique sequence of sncRNAs ensures the site-specificity of de novo epigenetic silencing 
being achieved. Additionally, piRNA is an effector for silencing of transposons in 
mammalian germ cells [198] and for establishing sequence-specific paternal DNA 
methylation imprinting during germline reprogramming in the mouse [199]. Endo-siRNA 
has now been shown to direct loci-specific histone H3K9 methylation and gene silencing 
through recruitment of H3K9 methyltransferase complexes in yeast [200].
The sperm-borne miRNA profiles are sensitive to various environmental exposures/
conditions including paternal obesity in mice [201], and chronic stress in male mice [196, 
202]. Such changes in sperm miRNA content correlated with transgenerational behavior and 
metabolic outcomes [201, 202]. Injection of stress-induced sperm miRNAs [196] or sperm 
total RNAs isolated from stressed males [202] recapitulated the offspring phenotype. 
Recently, ancestral exposure to vinclozolin induced transgenerational changes in specific 
miRNAs in primordial germ cells in F1 to F3 generations [37]. Information on the role of 
oocyte-borne sncRNAs in environmentally induced transgenerational phenomena is absent 
and warrants future investigations.
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Although early life environmental exposures appear to impact reproductive systems across 
multiple generations in animal models, it remains controversial as to whether these 
transgenerational effects are mediated via epigenetics [178, 203–206]. Hence, when 
interpreting data, other factors, such as exposure-induced changes in intrauterine 
environment and/or maternal behavior, must be taken into consideration due to their 
influence on offspring phenotypes [206]. Increasing challenges are anticipated in 
establishing transgenerational epigenetic inheritance in humans. Differences in epigenomes 
between mice and humans may not allow a direct extrapolation of data from mouse models 
[207]. Additionally, genetics may contribute to changing the epigenetic landscape through 
multiple human generations [207]. Therefore, genetic variations in human populations will 
always be confounding factor for studying transgenerational epigenetic inheritance in 
humans [206]. Shared environmental exposures across generations in humans may result in 
epigenetic alterations associated with phenotypic changes, rather than a consequence of 
transgenerational epigenetic inheritance [206].
6. Conclusion and future directions
This review has identified early embryonic and various other stages of fetal development as 
susceptible periods of reprogramming leading to increased risk for adult diseases (Figure 2). 
Some key features that make a cell or a tissue susceptible to reprogramming have also been 
discussed. These include cellular differentiation, rapid cell proliferation, and meiotic events, 
because large-scale chromatin condensation or relaxation is usually a key feature driving 
these processes. The fidelity and adequacy of enzymes, precursors, co-factors, and non-
coding RNAs responsible for chromatin modification, cell fate specification, and lineage 
commitment are critical for establishing a normal epigenome in the daughter cells. Due to 
the fact that these processes involve careful coordination among DNA methylation, histone 
modification, expression of non-coding RNAs, and other higher order chromatin sculpturing 
events, they are vulnerable to disruption by environmental agents. Literature pertaining to 
EDCs (BPA, genistein, DES, pp′-DDE, PAHs) that mimic the action of hormones, 
chemicals that activate morphogenic signaling (homeodomain proteins, retinoic acid, growth 
factors), nutritional imitators that disrupt the one-carbon cycle (folate), and activators of 
gene silencing RNAs (vinclozolin) were reviewed. The difference between epigenetic 
programming of somatic cells versus that required for germ cells has been emphasized. In 
this regard, the former experiences only one round of global erasure and re-establishment of 
epigenetic marks during differentiation from zygote-embryonic stem cells to fully 
differentiated cells. The latter undergo two rounds of massive epigenome re-sculpturing, one 
at the post-zygotic period and the second during primordial germ cell development. Since 
both phases occur in utero, it highlights the importance of prenatal exposure as the window 
of transmission of epigenetic inheritance through generations. Additional research is needed 
to explore toxicants capable of influencing inter- versus trans-generational transmission of 
epigenetic marks to fully appreciate their significance in human disease and health 
outcomes.
This review is by no means exhaustive, but rather seeking to address areas where major 
advancements have been made. Through the recognition of DOHaD as a root cause of 
exposure-associated reproductive dysfunctions, and the acknowledgement of epigenetics as 
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one mediator of the process, future focus can be placed on intervention strategies to mitigate 
the impacts of developmental disruption by these exposures. First, the identification of 
reliable epigenetic biomarkers linked to an exposure-related DOHaD dysfunction enables 
early detection and surveillance as countermeasures. Secondly, if these biomarkers could be 
applied to risk assessment algorithms, new recommendations for exposure limits can be 
made in public health policy-making. Finally, relevant questions to be addressed in the 
future may include: (1) the reversibility of epigenetic marks, (2) inter- verse trans-
generational inheritance, (3) exposomics or impacts of overall exposure across the life-
course, (4) advanced age as a window of susceptibility, (5) resident stem cells in adult 
tissues as targets, and (6) the biology of regenerative medicine.
Acknowledgments
This study was supported in part by grants from the National Institutes of Environmental Health Sciences and the 
National Cancer Institute: RC2ES018758 (SMH), RC2ES018789 (SMH), R01CA062269 (SMH), R01ES022071 
(SMH), R01ES015584 (SMH), R21ES013071 (SMH), U01ES019480 (SMH), U01ES020988 (SMH), 
P30ES006096 (SMH), the United States Department of Veterans Affairs I01BX000675 (SMH), R21CA156042 
(NNCT), and the Department of Defense Prostate Cancer Research Program W81XWH-15-1-0496 (AC). This work 
was also supported in part by the Intramural Research Program of the National Institutes of Health, National 
Institutes of Environmental Health Sciences, ZIAES102405 (CJW).
Abbreviations
BPA Bisphenol A
CpG 5′-C-phosphate-G-3′
DDT dichlorodiphenyltrichloroethane
DEET N,N-diethyl-meta-toluamide
DEHP bis(2-ethylhexyl)phthalate
DES Diethylstilbestrol
DNMT DNA methyltransferase
DOHaD Developmental Origins of Health and Disease
E Embryonic day
EDC Endocrine disrupting chemical
Endo-siRNA Endogenous small interfering RNA
ER Estrogen receptor
EZH2 Enhancer of zeste 2
F Filial
GD Gestational day
GPER1 G-protein coupled estrogen receptor 1
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HDAC Histone deacetylase
Hmgn5 High mobility group nucleosome biding protein 5
HOX Homeobox
H3K4me3 Trimethylated histone 3 lysine 4
H3K9ac Acetylated histone 3 at lysine 9
H3K9me2 Dimethylated histone 3 at lysine 9
H3K27me3 Trimethylated histone 3 at lysine 27
H4K5ac Acetylated histone 4 at lysine 5
miR/miRNA microRNA
NIEHS National Institute of Environmental Health Sciences
Nsbp1 Nucleosome binding protein 1
PAH Polycyclic aromatic hydrocarbon
PBDE Polybrominated dibenzoethers
PBE Polybrominated diphenylethers
PCB Polychlorinated biphenyl
PCDF Polychlorinated dibenzofuran
piRNA PIWI-interacting RNA
PND Postnatal day
pp′-DDE p,p′-dichlorodiphenyl-dichloroethylene
SAM S-adenosyl methionine
Six1 Sineoculis homeobox homolog 1
sncRNA Small noncoding RNA
TCDD 2,3,7,8-tetrachlorodibenzodioxin
TET Ten-eleven translocation
WNT Wingless type MMTV integration site family
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Highlights
• Epidemiological and model system studies support an early origin of 
reproductive dysfunction.
• Estrogenic and anti-androgenic chemicals as endocrine disrupting chemicals 
(EDCs) have broad developmental influences on adult reproductive outcomes.
• Gestational, perinatal, neonatal, and pubertal periods are “windows of 
susceptibility” for epigenetic programming.
• EDCs induce exposure-specific epigenetic modifications in homeobox genes, 
nucleosome binding proteins, and cell growth-regulated genes in organs of the 
reproductive system.
• Germline epigenetic disruption is a mechanism underlying transgenerational 
inheritance of reproductive disorders.
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Figure 1. 
Critical developmental stages of (A) human and (B) mouse reproductive systems, and 
windows of susceptibility for tissue reprogramming by environmental exposures. GD 
indicates gestational day; GW, gestational week; E, embryonic day; and PND, postnatal day.
Ho et al. Page 33
Reprod Toxicol. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. 
Environmental exposures induce dynamic methylome changes during post-zygotic and 
primordial germ cell (PGC) development resulting in inter- and trans-generational 
inheritance. The first phase is the rapid erasure of methylation marks in the male (blue line) 
and female (purple line) germline, that occurs shortly after fertilization. It is followed by the 
establishment of a new methylome in the implanting blastocyst. Progressive chromatin 
restriction gives rise to differentiated tissues. Environmental agents induce unique gene 
promoter methylation changes in different tissues. The second phase launched during sexual 
differentiation through birth establishes the sperm- and oocyte- specific heritable marks. 
Ovarian reserve (OvR) is determined at birth while male germ cells are replenished 
throughout life. Inter-generational transmission (light grey line) largely involves the first 
phase while transgenerational inheritance (dark grey line) requires both phases.
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 o
dd
s r
at
io
; H
R,
 h
az
ar
d 
ra
tio
; P
CB
, p
ol
yc
hl
or
in
at
ed
 b
ip
he
ny
l;
*
,
 
re
po
rte
d 
as
 n
ot
 st
at
ist
ic
al
ly
 si
gn
ifi
ca
nt
;
IR
R
, i
nc
id
en
ce
 ra
te
 ra
tio
; P
R,
 P
re
v
al
en
ce
 ra
tio
; B
PA
, b
isp
he
no
l A
; I
V
F,
 
in
 v
itr
o 
fe
rti
liz
at
io
n;
 P
CD
F,
 
po
ly
ch
lo
rin
at
ed
 d
ib
en
zo
fu
ra
n;
 P
FO
A
, p
er
flu
ro
ro
oc
ta
no
ic
 a
ci
d;
 P
FO
S,
 p
er
flu
or
oo
ct
an
e 
su
lfo
ni
c 
ac
id
, a
nd
 
TC
D
D
, 2
,3
,7
,8
-te
tra
ch
lo
ro
di
be
nz
od
io
xi
n.
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Ta
bl
e 
2
A
ni
m
al
 st
ud
ie
s –
 d
ev
el
op
m
en
ta
l o
rig
in
s o
f r
ep
ro
du
ct
iv
e 
dy
sf
un
ct
io
n 
as
so
ci
at
ed
 w
ith
 e
nv
iro
nm
en
ta
l f
ac
to
rs
.
Sp
ec
ie
s
Ex
po
su
re
O
bs
er
v
a
tio
n
D
ys
re
gu
la
te
d 
ge
ne
(s)
Ep
ig
en
et
ic
 m
ec
ha
ni
sm
R
ef
er
en
ce
D
os
e 
an
d 
ag
en
t
W
in
do
w
R
ou
te
W
in
do
w
 (A
ge
)
Ph
en
ot
yp
e
Fe
m
a
le
C
D
-1
 m
ou
se
50
 m
g/
kg
/d
ay
 G
EN
PN
D
1–
5
s.
c.
 in
jec
tio
n
3 
w
ee
ks
Cl
ito
ris
 w
as
 
ab
no
rm
al
ly
 
w
id
en
ed
 a
nd
 
er
yt
he
m
at
ou
s; 
u
re
th
ra
l o
pe
ni
ng
 
w
as
 lo
ca
te
d 
at
 
v
ar
yi
ng
 p
os
iti
on
s 
o
n
 th
e 
ve
n
tr
al
 
as
pe
ct
 o
f t
he
 
cl
ito
ris
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[9
5]
6 
w
ee
ks
Cl
ito
ris
 w
as
 le
ss
 
er
yt
hr
m
at
ou
s, 
u
re
th
ra
 o
pe
ni
ng
 
w
as
 a
bn
or
m
al
ly
 
po
sit
io
ne
d
[9
5]
C
D
-1
 m
ou
se
0,
 0
.0
02
 –
 2
 
μg
/p
up
/d
ay
 D
ES
PN
D
1–
5
s.
c.
 in
jec
tio
n
12
 m
on
th
s
Cy
sti
c 
en
do
m
et
ria
l 
hy
pe
rp
la
sia
, 
u
te
rin
e 
en
do
m
et
ria
l 
ad
en
oc
ar
ci
no
m
a
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[9
6]
C
D
-1
 m
ou
se
0 
or
10
0 
μg
/k
g 
BW
 
D
ES
G
D
9–
16
s.
c.
 in
jec
tio
n
1 
an
d 
18
 m
on
th
s
Va
gi
na
l a
de
no
sis
 
an
d 
ad
en
oc
ar
in
om
a
[9
7]
0,
 5
, 1
0,
 an
d1
00
 
μg
/k
g 
BW
 D
ES
G
D
9–
16
s.
c.
 in
jec
tio
n
1 
m
on
th
Va
gi
na
l a
de
no
sis
[9
7]
ze
br
af
ish
2.
76
 n
g/
L 
or
 9
.8
6 
n
g/
L 
EE
20
–6
0 
dp
f
En
v
iro
nm
en
ta
l
48
5 
dp
f
R
ed
uc
ed
 
pe
rc
en
ta
ge
 o
f 
su
rv
iv
in
g 
em
br
yo
s 
w
ith
 h
ig
h 
EE
 d
os
e
R
ed
uc
ed
 
ef
fe
ct
iv
en
es
s 
in
 
at
tr
ac
tin
g 
m
al
e 
at
te
nt
io
n 
w
ith
 h
ig
h 
EE
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[1
25
]
SD
 ra
ts
40
 μ
g/
kg
 B
W
 B
PA
G
es
ta
tio
n 
an
d 
la
ct
at
io
n
O
ra
l
PN
D
35
 an
d 
45
In
cr
ea
se
d 
in
v
es
tig
at
io
ns
 o
f 
pa
rtn
er
s, 
ex
pl
or
at
io
n 
of
 
en
v
iro
nm
en
t, 
ai
r 
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[1
26
]
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Sp
ec
ie
s
Ex
po
su
re
O
bs
er
v
a
tio
n
D
ys
re
gu
la
te
d 
ge
ne
(s)
Ep
ig
en
et
ic
 m
ec
ha
ni
sm
R
ef
er
en
ce
D
os
e 
an
d 
ag
en
t
W
in
do
w
R
ou
te
W
in
do
w
 (A
ge
)
Ph
en
ot
yp
e
sm
el
lin
g,
 a
nd
 
re
ar
in
g
PN
D
45
R
ed
uc
ed
 p
la
y 
be
ha
v
io
r w
ith
 
m
al
es
, p
ou
nc
e,
 a
nd
 
ch
as
in
g 
m
al
es
R
ed
uc
ed
 so
ci
al
 
be
ha
v
io
r a
nd
 
so
ci
al
 g
ro
om
in
g 
(ag
gre
ssi
v
e 
an
d 
al
lo
-g
ro
om
in
g)
[1
26
]
FV
B 
m
ic
e
0,
 0
.5
, 2
0,
 o
r 5
0 
μg
/k
g 
BW
/d
ay
 B
PA
0.
05
 μ
g/
kg
 B
W
/d
ay
 
D
ES
G
D
11
 ti
ll 
bi
rth
O
ra
l g
av
ag
e
PN
D
4
In
cr
ea
se
d 
nu
m
be
r 
o
f g
er
m
 c
el
ls 
to
 
re
m
ai
n 
in
 n
es
ts
R
ed
uc
ed
 n
um
be
r 
o
f p
rim
or
di
al
 
fo
lli
cl
es
 w
ith
 a
ll 
B
PA
 d
os
es
D
ec
re
as
ed
 ex
pr
es
sio
n 
o
f B
ax
,
 
Tn
frs
f1
1b
,
 
Tn
frs
f1
a, 
Tn
fd
f1
2,
 
an
d 
Lt
br
 
w
ith
 0
.5
 μ
g/
kg
 
B
W
/d
ay
 B
PA
;
In
cr
ea
se
d 
ex
pr
es
sio
n 
o
f B
cl
2l
1 
an
d 
de
cr
ea
se
d 
ex
pr
es
sio
n 
o
f B
ax
,
 
Ba
k1
,
 
an
d 
Tn
frs
f1
1b
 
w
ith
 2
0 
μg
/k
g 
BW
/d
ay
 B
PA
;
In
cr
ea
se
d 
ex
pr
es
sio
n 
o
f B
cl
2,
 
Bc
l2
l1
,
 
an
d 
de
cr
ea
se
d 
ex
pr
es
sio
n 
o
f B
ak
1,
 
Tn
frs
f1
1b
,
 
Tn
frs
f1
a, 
Tn
fd
f1
2,
 
an
d 
Lt
br
 
w
ith
 5
0 
μg
/k
g 
B
W
/d
ay
 B
PA
N
ot
 st
ud
ie
d
[1
12
]
A
fte
r P
N
D
21
Ea
rli
er
 v
ag
in
al
 
o
pe
ni
ng
 w
ith
 D
ES
Sh
or
te
r t
im
e 
be
tw
ee
n 
va
gi
na
l 
o
pe
ni
ng
 a
nd
 fi
rs
t 
es
tr
us
 w
ith
 D
ES
 
an
d 
50
 μ
g/
kg
/d
ay
 
B
PA
[1
12
]
3 
m
on
th
s
In
cr
ea
se
d 
nu
m
be
r 
o
f d
ea
d 
pu
ps
 w
ith
 
0.
5 
μg
/k
g 
BW
 
B
PA
6 
m
on
th
s
R
ed
uc
ed
 li
tte
r s
iz
e 
w
ith
 5
0 
μg
/k
g 
BW
 
B
PA
9 
m
on
th
s
O
nl
y 
on
e 
ou
t o
f 
fiv
e 
fe
m
al
es
 w
ith
 
ex
po
su
re
 to
 0
.5
 
μg
/k
g 
BW
 B
PA
 
[1
12
]
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Sp
ec
ie
s
Ex
po
su
re
O
bs
er
v
a
tio
n
D
ys
re
gu
la
te
d 
ge
ne
(s)
Ep
ig
en
et
ic
 m
ec
ha
ni
sm
R
ef
er
en
ce
D
os
e 
an
d 
ag
en
t
W
in
do
w
R
ou
te
W
in
do
w
 (A
ge
)
Ph
en
ot
yp
e
ga
v
e 
bi
rth
 a
nd
 w
ith
 
n
o
 li
v
e 
pu
ps
C
57
BL
/6
 m
ic
e
1 
m
g/
kg
 B
W
 B
aP
 o
r 
D
M
BA
Pr
ec
on
ce
pt
io
n:
 o
nc
e 
a 
w
ee
k 
fo
r t
hr
ee
 w
ee
ks
;
G
es
ta
tio
n:
 n
o 
tre
at
m
en
t;
La
ct
at
io
n:
 th
ird
 d
ay
 
af
te
r b
irt
h 
an
d 
th
en
 o
nc
e 
a 
w
ee
k 
fo
r t
hr
ee
 w
ee
ks
s.
c.
 in
jec
tio
n
3 
w
ee
ks
R
ed
uc
ed
 n
um
be
r 
o
f p
rim
or
di
al
 a
nd
 
pr
im
ar
y 
fo
lli
cl
es
 
ei
th
er
 e
ith
er
 
pr
eg
na
nc
y 
or
 
la
ct
at
io
na
l 
ex
po
su
re
 to
 P
A
H
Fo
lli
cu
la
r 
de
pl
et
io
n 
w
ith
 
pr
ep
re
gn
an
cy
 a
nd
 
la
ct
at
io
na
l 
ex
po
su
re
 o
f B
aP
W
ith
in
 2
4 
ho
ur
s o
f 
ex
po
su
re
: I
nc
re
as
ed
 
ex
pr
es
sio
n 
of
 H
rk
 
w
ith
 
PA
H
 e
x
po
su
re
N
ot
 st
ud
ie
d
[1
07
]
Su
llf
o
lk
 e
w
es
10
0 
m
g 
te
sto
ste
ro
ne
G
D
30
–9
0,
 tw
ic
e w
ee
kl
y
i.m
. i
nje
cti
on
G
D
14
0
R
ed
uc
ed
 fe
ta
l 
gr
ow
th
R
ed
uc
ed
 u
te
ru
s 
w
ei
gh
t w
ith
 T
R
ed
uc
ed
 n
um
be
r 
o
f d
ev
el
op
ed
 
fo
lli
cl
es
 p
er
 a
ni
m
al
 
w
ith
 T
R
ed
uc
ed
 to
ta
l 
n
u
m
be
r o
f f
ol
lic
le
s 
an
d 
pr
im
or
di
al
 
fo
lli
cl
es
 w
ith
 T
In
cr
ea
se
d 
ov
er
al
l 
to
ta
l n
um
be
r o
f 
pr
im
ar
y,
,
 
sm
al
l 
pr
ea
nt
ra
l, 
pr
ea
nt
ra
l, 
an
d 
an
tr
al
 fo
lli
cl
es
 
w
ith
 T
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[2
14
]
W
ist
ar
-
de
ri
v
ed
 r
at
s
0.
2 
or
 2
0 
μg
/k
g/
da
y 
D
ES
0,
 0
.0
5,
 o
r 2
0 
m
g/
kg
/d
ay
 B
PA
PN
D
1,
 3
, 5
, a
nd
 7
s.
c.
 in
jec
tio
n
G
D
18
La
ck
 o
f m
at
ur
e 
fo
lli
cl
es
 a
nd
 
fu
nc
tio
na
l c
or
pu
s 
lu
te
um
, a
nd
 n
o 
m
at
in
g 
be
ha
v
io
r 
w
ith
 2
0 
μg
/k
g/
da
y 
D
ES
R
ed
uc
ed
 n
um
be
r 
o
f i
m
pl
an
ta
tio
n 
sit
es
 w
ith
 0
.2
 
μg
/k
g/
da
y 
D
ES
 
an
d 
20
 m
g/
kg
/d
ay
 
B
PA
R
ed
uc
ed
 n
um
be
r 
o
f p
re
gn
an
t 
fe
m
al
es
 w
ith
 0
.2
 
μg
/k
g/
da
y 
D
ES
 
O
n 
G
D
5:
D
ec
re
as
ed
 ex
pr
es
sio
n 
o
f H
ox
10
a w
ith
 D
ES
 
an
d 
BP
A
 e
x
po
su
re
;
R
ed
uc
ed
 ex
pr
es
sio
n 
of
 
Itg
b3
 
an
d 
in
cr
ea
se
d 
ex
pr
es
sio
n 
of
 E
m
x2
 
w
ith
 0
.2
 μ
g/
kg
/d
ay
 
D
ES
 a
nd
 2
0 
m
g/
kg
/d
ay
 B
PA
N
ot
 st
ud
ie
d
[1
10
]
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Sp
ec
ie
s
Ex
po
su
re
O
bs
er
v
a
tio
n
D
ys
re
gu
la
te
d 
ge
ne
(s)
Ep
ig
en
et
ic
 m
ec
ha
ni
sm
R
ef
er
en
ce
D
os
e 
an
d 
ag
en
t
W
in
do
w
R
ou
te
W
in
do
w
 (A
ge
)
Ph
en
ot
yp
e
an
d 
0.
5 
or
 2
0 
m
g/
kg
 B
W
 B
PA
C
D
-1
 m
ic
e
5 
m
g/
kg
 B
PA
G
D
9–
16
i.p
. i
nje
cti
on
2 
w
ee
ks
N
ot
 st
ud
ie
d
In
cr
ea
se
d 
ex
pr
es
sio
n 
o
f H
ox
10
a
Pr
om
ot
er
 a
nd
 in
tro
ni
c 
hy
po
m
et
hy
la
tio
n
[1
40
]
FV
B 
m
ic
e
0.
05
 μ
g/
kg
/d
ay
 D
ES
0,
 0
.5
, 2
0,
 an
d 
50
 
μg
/k
g/
da
y 
BP
A
G
D
11
 ti
ll 
bi
rth
O
ra
l
9 
m
on
th
s
R
ed
uc
ed
 
pr
eg
na
nc
y 
ra
te
 
w
ith
 a
ll 
do
se
s o
f 
B
PA
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[2
15
]
C
D
-1
 m
ic
e
0 
or
 1
 m
g/
kg
/d
ay
 
D
ES
PN
D
1–
5
s.
c.
 in
jec
tio
n
PN
D
5
N
ot
 st
ud
ie
d
In
cr
ea
se
d 
ex
pr
es
sio
n 
o
f L
tf 
an
d 
Si
x1
R
ec
ru
itm
en
t o
f 
H
3K
9a
c, 
H
4K
5a
c a
nd
 
H
3K
4m
e3
 in
 ex
o
n
1/
in
tro
n1
 re
gi
on
 o
f S
ix
1
[1
46
]
C
D
-1
 m
ic
e
0 
or
 2
 μ
g/
m
ou
se
/d
ay
 
D
ES
PN
D
1–
5
s.
c.
 in
jec
tio
n
17
, 2
1,
 a
nd
 3
0 
da
ys
N
ot
 st
ud
ie
d
In
cr
ea
se
d 
ex
pr
es
sio
n 
o
f L
tf
H
yp
om
et
hy
la
ti 
on
 a
t 
th
re
e 
Cp
G
 si
te
s 
u
ps
tre
am
 o
f L
tf
[1
37
]
C
D
-1
 m
ic
e
0 
or
 1
0 
μg
/k
g 
BW
 
D
ES
G
D
9–
16
i.p
. i
nje
cti
on
2 
w
ee
ks
N
ot
 st
ud
ie
d
In
cr
ea
se
d 
ex
pr
es
sio
n 
o
f H
ox
a1
0 
in
 th
e 
ca
u
da
l r
eg
io
n,
 w
ith
 
de
cr
ea
se
d 
ex
pr
es
sio
n 
in
 th
e 
cr
an
ia
l a
re
a 
of
 
th
e 
ut
er
us
H
yp
er
m
et
hy
la
tio
n 
at
 
th
e 
pr
om
ot
er
 a
nd
 
in
tro
ni
c 
re
gi
on
s
[1
39
]
M
al
e
W
ist
ar
 r
at
s
0,
 6
0,
 o
r 3
00
 μ
g/
kg
 
B
W
 P
BD
E-
99
G
D
6
O
ra
l g
av
ag
e
PN
D
14
0
Sm
al
le
r t
es
te
s a
nd
 
re
du
ce
d 
ep
id
id
ym
is 
w
ei
gh
t
R
ed
uc
ed
 te
sti
cu
la
r 
sp
er
m
at
id
 c
ou
nt
 
an
d 
sp
er
m
 c
ou
nt
 
fro
m
 c
au
da
l 
ep
id
id
ym
is
R
ed
uc
ed
 d
ai
ly
 
sp
er
m
 p
ro
du
ct
io
n 
w
ith
 n
or
m
al
 sp
er
m
 
m
o
rp
ho
lo
gy
R
ed
uc
ed
 in
ci
de
nc
e 
o
f h
av
in
g 
tw
o
 o
r 
m
o
re
 e
jac
ula
tio
ns 
du
rin
g 
20
 m
in
ut
es
 
o
f m
at
in
g 
w
ith
 a
ll 
do
se
s o
f P
BD
E-
99
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[1
19
]
C
D
-1
 m
ic
e
0 
or
 1
00
 μ
g/
kg
 B
W
 
D
ES
G
D
9–
16
s.
c.
 in
jec
tio
n
7 
m
on
th
s
St
er
ili
ty
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[1
23
]
9–
10
 m
on
th
s
In
tra
-a
bd
om
in
al
 
te
st
es
, t
es
tic
ul
ar
 
[1
23
]
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Sp
ec
ie
s
Ex
po
su
re
O
bs
er
v
a
tio
n
D
ys
re
gu
la
te
d 
ge
ne
(s)
Ep
ig
en
et
ic
 m
ec
ha
ni
sm
R
ef
er
en
ce
D
os
e 
an
d 
ag
en
t
W
in
do
w
R
ou
te
W
in
do
w
 (A
ge
)
Ph
en
ot
yp
e
le
sio
ns
, a
nd
 
ep
id
id
ym
al
 cy
sts
SD
 ra
ts
0.
06
4,
 0
.1
6,
 0
.4
, 1
, 
o
r 
20
00
 μ
g/
kg
 B
W
 
TC
D
D
G
D
15
O
ra
l
PN
D
32
R
ed
uc
ed
 te
sti
s 
w
ei
gh
t w
ith
 th
e 
lo
w
es
t a
nd
 th
e 
tw
o
 
hi
gh
es
t d
os
es
 o
f 
TC
D
D
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[1
20
]
PN
D
49
 an
d 
63
R
ed
uc
ed
 te
sti
s 
w
ei
gh
t w
ith
 th
e 
hi
gh
er
 d
os
es
[1
20
,
 
12
1]
PN
D
32
, 4
9,
 6
3,
 
an
d 
12
0
R
ed
uc
ed
 
ep
id
id
ym
is 
w
ei
gh
t 
w
ith
 th
e 
hi
gh
es
t 
do
se
[1
20
]
PN
D
12
0
R
ed
uc
ed
 
ep
id
id
ym
is 
w
ei
gh
t 
w
ith
 th
e 
lo
w
es
t 
do
se
[1
20
]
PN
D
49
R
ed
uc
ed
 d
ai
ly
 
sp
er
m
 p
ro
du
ct
io
n 
w
ith
 d
os
es
 fr
om
 
0.
16
 μ
g/
kg
 B
W
[1
20
]
PN
D
63
 an
d 
12
0
R
ed
uc
ed
 d
ai
ly
 
sp
er
m
 p
ro
du
ct
io
n 
w
ith
 d
os
es
 fr
om
 
0.
06
4 
μg
/k
g 
BW
[1
20
]
SD
 ra
ts
0,
 0
.0
64
, 0
.1
6,
 0
.4
, 
o
r 
1 
μg
/k
g 
BW
 
TC
D
D
G
D
15
O
ra
l
PN
D
49
 an
d 
12
0
R
ed
uc
ed
 w
ei
gh
t o
f 
se
m
in
al
 v
es
ic
le
s 
w
ith
 0
.1
6 
μg
/k
g 
B
W
 T
CD
D
N
ot
 st
ud
ie
d
N
ot
 st
ud
ie
d
[1
21
]
PN
D
32
 a
nd
 1
20
R
ed
uc
ed
 w
ei
gh
t o
f 
v
en
tr
al
 p
ro
sta
te
 
w
ith
 0
.0
64
 μ
g/
kg
 
B
W
 T
CD
D
Lo
ng
 E
va
n
s 
H
oo
de
d 
ra
ts
0,
 0
.0
5,
 0
.2
, a
nd
 0
.8
 
μg
/k
g 
BW
 T
CD
D
G
D
15
O
ra
l g
av
ag
e
PN
D
49
R
ed
uc
ed
 w
ei
gh
t o
f 
se
m
in
al
 v
es
ic
le
 
an
d 
ve
n
tr
al
 
pr
os
ta
te
 w
ith
 0
.8
 
an
d 
1 
μg
/k
g 
BW
 
TC
D
D
R
ed
uc
ed
 to
ta
l 
ep
id
id
ym
al
 sp
er
m
 
co
u
n
t w
ith
 0
.8
 a
nd
 
1 
μg
/k
g 
BW
 
TC
D
D
[2
16
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s
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po
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O
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v
a
tio
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D
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gu
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Ep
ig
en
et
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 m
ec
ha
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er
en
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D
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en
t
W
in
do
w
R
ou
te
W
in
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w
 (A
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)
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en
ot
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e
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s
R
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 c
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l 
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al
 sp
er
m
 
co
u
n
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 0
.2
 a
nd
 
0.
8 
μg
/k
g 
BW
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D
D
R
ed
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ed
 c
au
da
l 
ep
id
id
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al
 sp
er
m
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u
n
t w
ith
 0
.0
5,
 
0.
2 
an
d 
0.
8 
μg
/k
g 
B
W
 T
CD
D
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16
]
C
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BL
/6
 m
ic
e
0,
 0
.1
, 1
, 1
0 
μg
/k
g 
B
W
 D
ES
G
D
12
-P
N
D
20
O
ra
l g
av
ag
e
PN
D
21
, 1
05
, a
nd
 
31
5
R
ed
uc
ed
 n
um
be
r 
o
f s
er
to
li 
ce
lls
 p
er
 
te
st
is
PN
D
21
:
Ex
pr
es
sio
n 
of
 C
yp
17
,
 
Cy
p1
1a
,
 
St
ar
 
w
er
e 
de
cr
ea
se
d 
w
ith
 1
0 
μg
/B
W
 D
ES
PN
D
10
5 
an
d 
31
5:
Ex
pr
es
sio
n 
of
 E
sr
1 
w
as
 d
ec
re
as
ed
 o
n 
w
ith
 
1 
μg
/k
g 
BW
 D
ES
 a
nd
 
u
n
de
te
ct
ab
le
 w
ith
 1
0 
μg
/k
g 
BW
N
ot
 st
ud
ie
d
[1
22
]
PN
D
31
5
R
ed
uc
ed
 c
au
da
l 
ep
id
id
ym
al
 sp
er
m
 
co
u
n
t,
In
cr
ea
se
d 
be
at
-
cr
o
ss
 fr
eq
ue
nc
y 
of
 
sp
er
m
 w
ith
 1
 a
nd
 
10
 μ
g/
kg
 D
ES
[1
22
]
PN
D
10
5 
an
d 
31
5
R
ed
uc
tio
n 
in
 th
e 
n
u
m
be
r o
f m
ot
ile
 
sp
er
m
, a
nd
 sp
er
m
 
m
o
til
ity
,
 
v
el
oc
ity
,
 
lin
ea
rit
y,
 
an
d 
A
LH
 
di
sp
la
ce
m
en
t
R
ed
uc
tio
n 
in
 
sp
er
m
 fe
rti
liz
in
g 
ab
ili
ty
 a
nd
 n
um
be
r 
o
f e
m
br
yo
s 
re
ac
hi
ng
 2
-c
el
l 
st
ag
e 
w
ith
 1
 μ
g/
kg
 
B
W
 D
ES
In
cr
ea
se
 in
 sp
er
m
 
fe
rti
liz
in
g 
ab
ili
ty
 
w
ith
 0
.1
 μ
g/
kg
 B
W
 
D
ES
[1
22
]
SD
 ra
ts
0,
 1
2.
5,
 2
5,
 5
0,
 1
00
 
m
g/
kg
 B
W
 G
EN
 
an
d 
2 
m
g/
kg
 B
W
 E
E
PN
D
1–
5
O
ra
l
7 
w
ee
ks
R
ed
uc
ed
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be
r 
o
f g
er
m
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ls 
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d
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ec
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Ex
po
su
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v
a
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n
D
ys
re
gu
la
te
d 
ge
ne
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ig
en
et
ic
 m
ec
ha
ni
sm
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ef
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en
ce
D
os
e 
an
d 
ag
en
t
W
in
do
w
R
ou
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W
in
do
w
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)
Ph
en
ot
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e
18
 w
ee
ks
Se
v
er
e 
at
ro
ph
y 
of
 
te
st
es
 a
nd
 
ep
id
yd
im
is 
w
ith
 
10
0 
m
g/
kg
 G
EN
R
ed
uc
ed
 p
ai
re
d 
ep
id
id
ym
al
 w
ei
gh
t 
w
ith
 a
ll 
do
se
s o
f 
G
EN
[1
24
]
G
EN
 in
di
ca
te
s g
en
ist
ei
n;
 P
N
D
, p
os
tn
at
al
 d
ay
; s
.c
., 
su
bc
ut
an
eo
us
; D
ES
, d
ie
th
yl
sti
lb
es
tro
l; 
BW
,
 
bo
dy
 w
ei
gh
t; 
G
D
, g
es
ta
tio
na
l d
ay
; E
E,
 e
th
in
yl
 e
str
ad
io
l; 
dp
f, 
da
y 
po
st-
fe
rti
liz
at
io
n;
 S
D
 S
pr
ag
ue
-D
aw
le
y;
 B
PA
, 
bi
sp
he
no
l A
; B
aP
,
 
be
nz
o(a
)py
re
ne
; D
M
BA
, 7
,1
2-
D
im
et
hy
lb
en
z[a
]an
thr
ac
en
e; 
PA
H
, p
ol
yc
yc
lic
 a
ro
m
at
ic
 h
yd
ro
ca
rb
on
; i
.m
., 
in
tra
m
us
cu
la
r; 
T,
 
te
st
os
te
ro
ne
; i
.p
., 
in
tra
pe
rit
on
ea
l; 
H
3K
9a
c, 
ac
et
yl
at
ed
 h
ist
on
e 3
 
at
 ly
sin
e 
9;
 H
4K
5a
c, 
ac
et
yl
at
ed
 h
ist
on
e 4
 at
 ly
sin
e 5
; H
3K
4m
e3
, t
rim
et
hy
la
te
d 
hi
sto
ne
 3
 a
t l
ys
in
e 
4;
 P
BD
E-
99
, 2
,2
′,4
,4
′,5
-p
en
ta
br
om
od
ip
he
ny
l e
th
er
; T
CD
D
, 2
,3
,7
,8
-te
tra
ch
lo
ro
di
be
nz
o-
p-
di
ox
in
; a
nd
 A
LH
, 
am
pl
itu
de
 o
f l
at
er
al
 h
ea
d.
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